Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
136 Cards in this Set
- Front
- Back
resting membrane potential of a cell
|
-70 mV
|
|
There is net excess of positive or negative charge inside cell? why?
|
excess negative charge due to abundace of protein and nucleic acids
|
|
which ion is the most permeable at rest?
|
potassium
|
|
which ion is least permeable at rest?
|
sodium
|
|
which two forces cause ions to want to move?
|
concentration gradient
electical force |
|
T/F Sodium is more concentrated outside the cell at rest.
|
T
|
|
T/F Potassium is more concentrated inside the cell at rest.
|
T
|
|
T/F Sodium has a tendency to want to move out of the cell at rest.
|
F---it wants to move into cell at rest, down its conc. gradient
|
|
T/F Potassium wants to move outside the cell at rest.
|
T
|
|
What is the Nernst Potential?
|
tells us what the membrane potential would have to be for the electrical force to cancel out the concentration force
|
|
What is driving force and how is it calculated?
|
the net force on an ion to diffuse; is the difference between the membrane potential and the nernst potential for that ion
|
|
what is the nernst potential for sodium? Calculate driving force with this information.
|
+70mV; D.F. = 140 mV (difference between -70mV [membrane potential] and nernst potential)
|
|
flux?
|
permeability * driving force
|
|
at rest the most permeable ion is...
|
potassium
|
|
T/F The membrane potential will most closely represent the nernst potential for the most permeable ion.
|
T
|
|
The Na/K pump pumps out how many Na ions and pumps in how many K ions?
|
pumps out 3 Na ions for every 2 K ions it pumps in. (constantly moving net negative charge into cell)
|
|
threshold for generating an action potential
|
-50 mV
|
|
what is depolarization
|
Na becomes more permeable, leaks into cell "removing" membrane potential from -70mV to 0mV
|
|
what is overshoot?
|
membrane potential becomes positive, up to 30mV
|
|
what is repolarization?
|
membrane potential returns back to -70mV as potassium leaks out of cell
|
|
what is afterhyperpolarization?
|
membrane potential briefly drops below -70mV making it harder to reach threshold and generate another action potential (relative refractory period)
|
|
how do we change an ions permeability?
|
by opening/closing voltage gated ion channels
|
|
T/F
sodium channels have two gates and potassium channels have one gate |
T
|
|
what happens to both K and Na gates as threshold is reached?
|
they open
|
|
Why don't the gates cancel each other out at threshold?
|
Na has much larger driving force and flows more rapidly into cell; K's gates open slower
|
|
what causes afterhyperpolarization?
|
Na gates closed; K gates still open
|
|
T/F At rest, the inactivation gate is open and the activation gate is closed for Na channel.
|
T
|
|
Physiologically, what is the absolute refractory period.
|
The period of time when the inactivation gate is closed.
|
|
When does the inactivation gate reopen?
|
When membrane potential gets below threshold (-50mV)
|
|
When does the potassium gate open?
|
when threshold is reached
|
|
When does repolarization occur?
|
When Na channels close (inactivation gate closes) and K gates fully open.
|
|
When does activation gate close?
|
during repolarization
|
|
define antidromic
|
an action potential that travels toward the cell body
|
|
define orthodromic
|
an action potential that travels toward axon terminal
|
|
glial cells in the peripheral n.s.
|
Schwann cells
|
|
insulating cells in central n.s.
|
oligodendrocytes
|
|
type of pain via "c-fibers"
|
achy dull pain
|
|
T/F action potentials regenerate at the nodes of ranvier b/c this is where the voltage gates channels are located.
|
T
|
|
what is saltatory conduction
|
the skipping of the action potential from node to node
|
|
what prevents reverberation along an axon?
|
the absolute refractory period---(the node previous to the location of the A.P. cannot depolarize again)
|
|
T/F vesicles are loaded with Neurotransmitter via ATP at axon terminal
|
T
|
|
purpose of the presynaptic density
|
holds vesicles in place
prevents premature fusing of vesicles and exocytosis of NT |
|
two proteins that compose presynaptic density
|
actin (tether ball post) and synapsin (rope from post into tether ball) [vesicle is tether ball]
|
|
type of Ca channels located in region of synapse
|
n-type Ca channels
|
|
what happens to Ca channels when an AP arrives?
|
they open, allowing Ca to enter the neuron flowing down its Ec gradient
|
|
what happens when ca enters the neuron and binds to calcineurin?
|
inactivates Ca channels
|
|
what occurs when Ca enters neuron and binds to calmodulin?
|
activates calmodulin-dependent protein kinase (CAM kinase)
|
|
what does CAM-kinase do?
|
phosphorylates synapsin which releases vesicle to fuse with membrane and dump NT
|
|
purpose of "docking stations"?
|
activated by Ca, membrane bound proteins that aid exocytosis of NT
|
|
fates of NT after it is released?
|
binds to receptors
diffuse out of cleft and into blood (washout) metabolized to diff. structure pumped back in |
|
primary excitatory NT in CNS
|
glutamate
|
|
primary inhibitory NT of brain
|
GABA
|
|
primary inhibitory NT in spinal chord
|
glycine
|
|
type of channels in post-synaptic cells
|
ligand-gated channels
|
|
what is the ligand in the post-synaptic cell?
|
the NT
|
|
What is EPSP?
|
excitatory post-synaptic potential; a gate opening for both K and Na---mV goes to -20mV, closer to threshold
|
|
What is IPSP?
|
inhibitory post-synaptic potential; gate permeable to Cl that results in hyperpolarization and far from threshold
|
|
Two types of summation for IPSP and EPSP
|
temporal and spatial summation
|
|
what is temporal summation?
|
a second psp occurs before complete decrement of the first psp (same location)
|
|
what is spatial summation?
|
multiple psp's are generated at same time in different locations.
|
|
type of summation if an IPSP and an EPSP are summed
|
spatial (different locations)
|
|
where are most EPSPs generated?
|
dendrites
|
|
where are most IPSPs generated?
|
soma or cell body
|
|
Why are ISPSs more poweful than EPSPs?
|
b/c of sites of origin, ipsps move a shorter distance, lose less charge and can inhibit multiple epsps
|
|
n.s. utilized when aware of a decision
|
somatic nervous system
|
|
involuntary n.s.
|
autonomic nervous system
|
|
two parts of autonomic nervous system
|
sympathetic (F or F)
parasympathetic (rest/dig) |
|
sympathetic n.s. encompasses which portions of vertebral column
|
thoracolumbar
|
|
parasympathetic n.s. encompasses which portions of vertebral column
|
craniosacral
|
|
which nerve plays an important part in parasympathetic activity
|
vagus nerve
|
|
what is a ganglion?
|
nucleus outside of cns
|
|
symp. preganglionic fibers: long or short?
|
short
|
|
all preganglionic fibers: myelinated or unmyelinated?
|
myelinated
|
|
symp postganglionic fibers: long or short?
|
long
|
|
all postganglionic fibers: myelinated or unmyelinated?
|
unmyelinated
|
|
parasympathetic preganglionic fibers: long or short?
|
long
|
|
parasympathetic postganglionic fibers: long or short?
|
short
|
|
T/F: every axon exiting cns is myelinated
|
T
|
|
2 types of receptors for acetylcholine?
|
nicotinic
muscarinic |
|
T/F: the first synapse involving acetylcholine is a nicotinic receptor?
|
T
|
|
parasympathetic n.s.: type of receptor found on target cells following pre/post ganglionic travel
|
muscarinic
|
|
beta-1 receptors located in...
|
heart
|
|
beta-2 receptors located in....
|
lungs
|
|
beta-3 receptors located in...
|
adipocytes
|
|
two types of receptors for acetylcholine
|
nicotinic
muscarinic |
|
enzyme that makes acetylcholine
|
choline acetyltransferase
|
|
Ach receptor for somatic activity to muscle cells
|
nicotinic
|
|
Ach receptor type in TARGETcells of para/symp n.s.
|
muscarinic
|
|
Ach receptor type in 1st synapse in para/symp n.s.
|
usually nicotinic
|
|
Ach receptor type fo splanchnic nerve
|
nicotinic
|
|
enzyme that metabolizes Ach after exocytosis into choline and acetate
|
choline esterases
|
|
effect of beta-bungaro toxin (black widow spider venom)
|
hyper-release of vesicles depleting #
|
|
effect of botulism toxim
|
prevent exocytosis
|
|
hemicholinium
|
deplete Ach--choline is scarce
|
|
neostigmine, physostigmine, malathion and nerve gas: mechanism of action
|
overstimulation; prolongs Ach exocytosis
|
|
3 nicotinic agonists
|
Ach
nicotine carbachol |
|
3 nicotinic antagonists
|
curare
succinyl choline rabies virus |
|
3 muscarinic agonists
|
Ach
muscarine pilocarpine oxotremorine |
|
3 muscarinic antagonists
|
atropine
scopolamine |
|
how do nicotinic receptors work?
|
ionophore---nonspecific conductance pore through the membrane (Na and K can pass--EPP)
|
|
how do muscarinic receptors work?
|
use of G-proteins as coupling agents
|
|
inhibiting adenylate cyclase does what?
|
dec. cAMP in cells
|
|
guanylate cyclase stimulation..
|
inc. cGMP in cells
|
|
stimulate phospholiase c
|
inc DAG, IP3, and Ca
|
|
what is tyrosine used to make?
|
catecholamines
|
|
three catecholamines..
|
NE
epi dopamine |
|
what do the catecholamines share as a precursor?
|
L-tyrosine
|
|
enzyme that adrenal medulla cells express to make epinephrine.
|
PMNT enzyme
|
|
1) L-tyrosine to L-dopa via...
|
tyrosine hydroxylase
|
|
2) L-dopa to dopamine via...
|
dopa decarboxylase
|
|
3) dopamine to norepi via...
|
dopamine beta hydroxylase
|
|
4) norepi to epi via...
|
PMNT enzyme
|
|
action of alpha-methyl tyrosine, alpha methyl dopa, diethyldithiocarbamate:
|
depletes transmitter
|
|
action of amphetamines
|
initial release but long term depletion (crash later)
|
|
what is cortisol? what does it do?
|
stress hormone; inc. epi synthesis in medulla
|
|
action of cocaine, desipramine,
|
increased NE in cleft but inhibits reuptake; long term depletion
|
|
action of reserpine
|
inhibits recycling of NE
|
|
waste product of norepi in urine
|
vanillylmandelic (VMA)
|
|
two enzymes producing endproduct of norepi in urine
|
monoamine oxidase (MAO)
catechol-o-methyl transferase (COMT) |
|
effect of MAO inhibitors
|
inc. DA, epi and Norepi in nerve terminals (more into vesicles)
|
|
practical uses for MAOI's
|
antidepressants and blood pressure regulators
|
|
T/F Norepi/dopamine are NT in cns as well as pns
|
T
|
|
name of the source of noradrenergic neurons
|
locus coeruleus
|
|
source of dopamine in the brain
|
substantia nigra
|
|
5 subtypes of dopamine receptors
|
D1 to D5
|
|
what do dopamine receptors do?
|
alter cAMP in target cells (inc. adenylate cyclase activity)
|
|
more potent stimulus: epi or norepi?
|
epi
|
|
what are adrenergic receptors
|
receptors for epi and norepi
|
|
T/F adrenergic receptors are located in both the cns and pns
|
T
|
|
primary antagonist for alpha-adrenergic receptors
|
phenoxybenzamine
|
|
primary agonist for all beta-adrenergic receptors
|
isoproterenol
|
|
primary antagonist for all beta-adrenergic receptors
|
propranolol
|
|
agonist for beta-1 adrenergic receptors
|
dobutamine
|
|
antagonist for beta-1 adrenergic receptors
|
atenolol
|
|
where are beta-3 adrenergic receptors located?
|
adipocytes
|
|
beta-2 adrenergic receptor agonist
|
albuterol
|